ABOUT HUGEL

New Hope, Better Life

History

COMMERCIALIZATION

  • 2011
    12
    Received IND approval for phase III clinical trial for pediatric cerebral palsy
    10
    Received KFDA approval for Botulax® 50 units
    09
    Awarded as "Prime Minister Prize of Innovative Product Botulax"
    on the Local Development Week in 2011
    Received KFDA approval for Botulax® 200 units
    07
    Received IND approval for phase III clinical trial for glabellar lines
    06
    Initiation of approval process for international commercialization
  • 2010
    12
    Obtained first overseas marketing approval for botulinum toxin in Peru
    03
    Received KFDA approval for botulium toxin(blepharospasm)
    02
    Received EN ISO 13485 certification for medical equipment quality control system
  • 2009
    06
    Established Hugel Pharma, a marketing subsidiary
    03
    Received KFDA approval for botulium toxin export
  • 2008
    11
    Certified as a venture company(Korean Venture Capital Association)
  • 2007
    09
    Received IND approval for phase III clinical trial for blepharospasm
  • 2006
    10
    Completed construction of KGMP plant in Techno Park, Chuncheon